Antipsychotic dose escalation as a trigger for Neuroleptic Malignant Syndrome (NMS): literature review and case series report

BACKGROUND: “Neuroleptic malignant syndrome” (NMS) is a potentially fatal idiosyncratic reaction to any medication which affects the central dopaminergic system. Between 0.5% and 1% of patients exposed to antipsychotics develop the condition. Mortality rates may be as high as 55% and many risk facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Langan, Julie, Martin, Daniel, Shajahan, Polash, Smith, Daniel J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Database
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546951/
https://www.ncbi.nlm.nih.gov/pubmed/23194104
http://dx.doi.org/10.1186/1471-244X-12-214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546951/
https://www.ncbi.nlm.nih.gov/pubmed/23194104
http://dx.doi.org/10.1186/1471-244X-12-214

Ejemplares similares